Literature DB >> 15853466

Expression of myelencephalon-specific protease after cryogenic lesioning of the rat parietal cortex.

Yuichi Oka1, Atsushi Uchida, Mineyoshi Aoyama, Masataka Fujita, Naokazu Hotta, Toyohiro Tada, Hiroyuki Katano, Mitsuhito Mase, Kiyofumi Asai, Kazuo Yamada.   

Abstract

The gene for myelencephalon-specific protease (MSP) is a member of the kallikrein gene family and in rats is expressed mainly in the central nervous system. Its function and alteration in brain injury have not yet been clarified. We examined the expression of MSP after cryogenic injury (CI) using in situ hybridization, immunohistochemistry, and Western blotting. Analysis of MSP mRNA by in situ hybridization revealed a higher level of expression around the cryogenic area than on the contralateral side at 2-7 days after CI, with peak expression occurring 7 days after CI. Immunohistochemical analysis demonstrated expression of MSP protein at 1 day after CI, in the same region in which MSP mRNA was observed, with peak expression again at 7 days after CI, in the area around the lesion. Double immunohistochemical labeling revealed that MSP was expressed mainly in oligodendrocytes. These results suggest that expression of MSP may be related to the turnover of myelin-associated proteins and extracellular matrix proteins after CI. The regulation of active MSP may be important in the physiological or pathological changes involved in remyelination or demyelination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853466     DOI: 10.1089/neu.2005.22.501

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  2 in total

1.  Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.

Authors:  Hyesook Yoon; Sachiko I Blaber; D Michael Evans; Julie Trim; Maria Aparecida Juliano; Isobel A Scarisbrick; Michael Blaber
Journal:  Protein Sci       Date:  2008-08-12       Impact factor: 6.725

2.  Correlation between KLK6 expression and the clinicopathological features of glioma.

Authors:  Jiangtao Lou; Haiyan Si; Yingjian Chen; Xiaoming Sun; Hua Zhang; Aijun Niu; Chengjin Hu
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.